FMO5 and atherosclerosis: Aging also correlates with vascular dysfunction and atherosclerosis, where endothelial nitric oxide (NO) bioavailability declines due to reduced endothelial nitric oxide synthase (eNOS) activity, while pro-oxidant NADPH oxidase enzymes become overactive [57].